Loading…
OKYO Pharma Limited is projected to rise to $2.29 by 2027, a +36% move from its current price of $1.68. OKYO is currently trading above its 50-day average (a bullish sign). Technical indicators currently lean buy.
A data-driven summary — not financial advice. See the full breakdown below.
Live market data via Yahoo Finance · updated 8/3/2026
| Period | Min | Prediction | Max | Change |
|---|---|---|---|---|
| Aug 5 | $1.63 | $1.68 | $1.74 | +0.11% |
| Aug 6 | $1.61 | $1.68 | $1.76 | +0.22% |
| Aug 7 | $1.60 | $1.69 | $1.78 | +0.32% |
| Aug 8 | $1.58 | $1.69 | $1.80 | +0.43% |
| Aug 9 | $1.57 | $1.69 | $1.81 | +0.54% |
| Aug 10 | $1.56 | $1.69 | $1.83 | +0.65% |
| Aug 11 | $1.56 | $1.69 | $1.84 | +0.76% |
| Period | Min | Prediction | Max | Change |
|---|---|---|---|---|
| Week 1 | $1.56 | $1.69 | $1.84 | +0.76% |
| Week 2 | $1.51 | $1.71 | $1.92 | +1.52% |
| Week 3 | $1.49 | $1.72 | $1.99 | +2.29% |
| Week 4 | $1.46 | $1.73 | $2.05 | +3.06% |
| Week 5 | $1.45 | $1.74 | $2.10 | +3.84% |
| Week 6 | $1.43 | $1.76 | $2.16 | +4.63% |
| Week 7 | $1.42 | $1.77 | $2.21 | +5.42% |
Short-term targets derived from the forecast trend and recent volatility. Highly uncertain — not financial advice.
OKYO Pharma Limited is a clinical-stage biopharmaceutical company that develops therapeutics for patients suffering from inflammatory eye diseases and ocular pain in the United Kingdom. Its lead clinical product candidate is urcosimod, which is in Phase II clinical trials for the treatment of dry eye disease; in Phase II clinical trial to treat neuropathic corneal pain; and is in preclinical trial to treat allergic conjunctivitis and uveitis. The company is also developing OK-201 for the treatment acute and chronic ocular pain.
OKYO Pharma Limited was incorporated in 2007 and is headquartered in London, the United Kingdom.
OKYO Pharma Limited (OKYO) trades at $1.64 per share and has a market capitalization of $86.07M. The company is ranked 4085. The current price sits near the lower end of a forecast path that shows near term neutrality in 2026 and bullish growth thereafter, with the average price advancing to multi year highs by 2050.
In 2026 the forecast lists an average price of $1.64, rising in the following years to $2.68 by 2030 and $12.24 by 2050, indicating a long term uptrend.
A major floor 27.4% below — a decisive break under it would weaken the trend.
The nearest floor, 18.5% below — buyers have tended to step in here.
The nearest ceiling, 4.2% above — a clean break opens room to run.
A major ceiling 17.9% above — clearing it would confirm fresh momentum.
Key OKYO support and resistance from recent price action — levels where the trend has historically paused or reversed. Percentages are the distance from the current price.
A snapshot of OKYO market posture derived from its technical indicators and recent volatility. Higher trend and alignment lean bullish; higher risk means larger swings.
Technical Analysis
Indicators computed on daily closing prices.
| Period | SMA | Action | EMA | Action |
|---|---|---|---|---|
| MA 5 | $1.65 | Buy | $1.64 | Buy |
| MA 10 | $1.56 | Buy | $1.60 | Buy |
| MA 20 | $1.57 | Buy | $1.58 | Buy |
| MA 50 | $1.59 | Buy | $1.58 | Buy |
| MA 100 | $1.60 | Buy | $1.65 | Buy |
| MA 200 | $1.86 | Sell | $1.75 | Sell |
| Name | Value | Action |
|---|---|---|
| RSI (14) | 58.91 | Neutral |
| Stoch RSI (14) | 100.00 | Sell |
| CCI (20) | 76.76 | Neutral |
| Williams %R (14) | 0.00 | Info |
| MACD (12,26,9) | 0.02 | Buy |
| ROC (12) | 12.75 | Buy |
| Bollinger %B (20,2) | 0.75 | Neutral |
| Stochastic %K (14) | 100.00 | Sell |
| TRIX (15) | -0.07 | Sell |
| Awesome (5,34) | 0.09 | Buy |
| Ultimate (7,14,28) | 72.17 | Sell |
| Momentum (10) | 0.25 | Buy |
| Aroon Osc (25) | -36.00 | Sell |
| Hull MA (9) | 1.70 | Sell |
| ADX (14) | 13.41 | Neutral |
| ATR (14) | 0.05 | Info |
The 30-day technical picture is bullish with RSI(14) at 60.0. The stock’s 50-day simple moving average is $1.58 and the 200-day simple moving average is $1.87. Support is at $1.37 and resistance at $1.75, with a 30-day price range from $1.26 to $2.13.
| Year | Min | Avg | Max | ROI | Sentiment |
|---|---|---|---|---|---|
| $1.37 | $1.68 | $2.53 | 0% | Neutral | |
| $1.80 | $2.29 | $3.09 | +36% | Bullish | |
| $2.05 | $2.70 | $3.80 | +60% | Bullish | |
| $2.04 | $2.76 | $4.03 | +64% | Bullish | |
| $2.10 | $2.92 | $4.37 | +74% | Bullish | |
| $2.39 | $3.39 | $5.20 | +102% | Bullish | |
| $2.57 | $3.72 | $5.84 | +122% | Bullish | |
| $3.23 | $4.76 | $7.62 | +184% | Bullish | |
| $3.64 | $5.48 | $8.92 | +226% | Bullish | |
| $3.39 | $5.19 | $8.60 | +209% | Bullish | |
| $5.20 | $8.64 | $15.33 | +414% | Bullish | |
| $7.93 | $15.22 | $29.81 | +806% | Bullish |
Current year — the forecast is anchored to the live price, so ROI shows 0%.
| Month | Min | Avg | Max | Change |
|---|---|---|---|---|
| August 2026 | $1.37 | $1.68 | $2.07 | +0.00% |
| September 2026 | $1.46 | $1.74 | $2.13 | +3.35% |
| October 2026 | $1.55 | $1.85 | $2.30 | +6.75% |
| November 2026 | $1.64 | $1.98 | $2.48 | +6.84% |
| December 2026 | $1.65 | $2.00 | $2.53 | +1.11% |
Click any year to see its month-by-month OKYO forecast. Min / Avg / Max are a bear / base / bull scenario; ROI is the projected move from the current price. Change is the month-over-month move in the average. Estimates, not guarantees.
The OKYO price prediction for 2026 points to an average of $1.68 (low $1.37, high $2.53) — a potential gain of 0% on today's $1.68. A consolidation phase looks the most probable path here.
In 2027, OKYO is projected to trade between $1.80 and $3.09, averaging $2.29 — a potential gain of +36% from today's $1.68. That is up +36% on the projected 2026 average. Momentum favours further upside here.
OKYO Pharma Limited's 2028 outlook centres on $2.70, within a $2.05 to $3.80 range. That is up +18% on the projected 2027 average. That marks a +60% change versus current levels. Buyers look set to stay in control over this stretch.
By 2029, OKYO could reach as high as $4.03, with a base case around $2.76 and support toward $2.04 — roughly +64% from $1.68. Momentum favours further upside here.
Expect OKYO to range from $2.10 to $4.37 through 2030. The $2.92 average target implies a +74% move from current prices. That is up +6% on the projected 2029 average. Buyers look set to stay in control over this stretch.
The OKYO price prediction for 2031 points to an average of $3.39 (low $2.39, high $5.20) — a potential gain of +102% on today's $1.68. Momentum favours further upside here.
In 2032, OKYO is projected to trade between $2.57 and $5.84, averaging $3.72 — a potential gain of +122% from today's $1.68. That is up +10% on the projected 2031 average. Buyers look set to stay in control over this stretch.
OKYO Pharma Limited's 2033 outlook centres on $4.76, within a $3.23 to $7.62 range. That is up +28% on the projected 2032 average. That marks a +184% change versus current levels. Momentum favours further upside here.
By 2034, OKYO could reach as high as $8.92, with a base case around $5.48 and support toward $3.64 — roughly +226% from $1.68. Buyers look set to stay in control over this stretch.
Expect OKYO to range from $3.39 to $8.60 through 2035. The $5.19 average target implies a +209% move from current prices. That is -5% versus the projected 2034 average. Momentum favours further upside here.
The OKYO price prediction for 2040 points to an average of $8.64 (low $5.20, high $15.33) — a potential gain of +414% on today's $1.68. Buyers look set to stay in control over this stretch.
In 2050, OKYO is projected to trade between $7.93 and $29.81, averaging $15.22 — a potential gain of +806% from today's $1.68. That is up +76% on the projected 2040 average. Momentum favours further upside here.
Investing $1,000 in OKYO today (≈ 595.238095 OKYO) could be worth
$9,061.58
+$8,061.58 (+806%) by 2050 · US Dollar
Based on the average projected OKYO price of $15.22 in 2050.
Based on the base (average) forecast scenario. FX rates are indicative. Estimates only — not financial advice.
See what a past investment in OKYOwould be worth at today's price.
$1,000 invested in OKYO on Jul 31, 2025 (≈ 370.370364 OKYO) would be worth
$622.22
-$377.78 (-37.8%) today · 0.62× · US Dollar
Based on a OKYO entry price of $2.7 vs. today's $1.68.
| Invested | Entry price | Value today | Return |
|---|---|---|---|
| 1 week ago | $1.55 | $1,083.87 | +8.4% |
| 1 month ago | $1.5 | $1,120 | +12.0% |
| 3 months ago | $1.66 | $1,012.05 | +1.2% |
| 6 months ago | $2.09 | $803.83 | -19.6% |
| 1 year ago | $2.7 | $622.22 | -37.8% |
| All time (4.2y) ago | $3.62 | $464.09 | -53.6% |
Past performance from historical market data — it does not predict future results. FX rates are indicative. Not financial advice.
Enter a price to see how it sits against our OKYO forecast.
Our base-case forecast reaches $3.40 around 2032.
Implied market cap at $3.40: $178.43M
The multi year forecast shows a bullish trend beginning in 2027 and continuing through 2050. In 2027 the average price is $2.27 and the outlook remains positive thereafter, with the 2030 average at $2.68 and a max of $4.25 (min $1.84, ROI 63.6, sentiment BULLISH). By 2040 the average price is forecast at $7.50 with a max of $14.46 (min $4.01, ROI 357.6, sentiment BULLISH).
In 2050 the average price is forecast at $12.24 with a max of $26.41 (min $5.51, ROI 646.6, sentiment BULLISH). These figures illustrate a substantial long term upside potential alongside inherent uncertainty and risk.
Tap a question to reveal the answer.
2030 avg $2.68, min $1.84, max $4.25, ROI 63.6, sentiment BULLISH.
Forecasts show bullish sentiment from 2027 onward with rising averages through 2050 (2030 avg $2.68; 2040 avg $7.50; 2050 avg $12.24) and ROI values listed; these are estimates, not guarantees.
Yes. The forecast max in 2040 is $14.46, which exceeds $10, and the 2050 max is $26.41.
$1.26 to $2.13.
Current price is $1.64 and market cap is $86.07M.
OKYO Pharma Limited Community Discussion
0Share your OKYO Pharma Limited price prediction and read what the community thinks. Be respectful — comments are public and not financial advice.
Be the first to share your prediction…
What's your take? Add a comment above to start the conversation.